vs

Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Healthcare Realty Trust Inc (HR). Click either name above to swap in a different company.

Healthcare Realty Trust Inc is the larger business by last-quarter revenue ($279.0M vs $205.4M, roughly 1.4× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs -0.0%, a 8.3% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 5.9%). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -6.1%).

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.

Duke Realty was a real estate investment trust (REIT) based in Indianapolis, Indiana, that invested in industrial properties. As of December 31, 2021, it owned or jointly controlled 548 primarily industrial properties containing 162.7 million rentable square feet. In October 2022, it was acquired by Prologis.

COLL vs HR — Head-to-Head

Bigger by revenue
HR
HR
1.4× larger
HR
$279.0M
$205.4M
COLL
Growing faster (revenue YoY)
COLL
COLL
+7.0% gap
COLL
12.9%
5.9%
HR
Higher net margin
COLL
COLL
8.3% more per $
COLL
8.3%
-0.0%
HR
Faster 2-yr revenue CAGR
COLL
COLL
Annualised
COLL
19.1%
-6.1%
HR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
COLL
COLL
HR
HR
Revenue
$205.4M
$279.0M
Net Profit
$17.0M
$-56.0K
Gross Margin
62.5%
Operating Margin
29.6%
Net Margin
8.3%
-0.0%
Revenue YoY
12.9%
5.9%
Net Profit YoY
35.3%
EPS (diluted)
$0.48
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COLL
COLL
HR
HR
Q1 26
$279.0M
Q4 25
$205.4M
$286.3M
Q3 25
$209.4M
$297.8M
Q2 25
$188.0M
$297.5M
Q1 25
$177.8M
$299.0M
Q4 24
$181.9M
$309.8M
Q3 24
$159.3M
$315.4M
Q2 24
$145.3M
$316.3M
Net Profit
COLL
COLL
HR
HR
Q1 26
$-56.0K
Q4 25
$17.0M
$14.6M
Q3 25
$31.5M
$-57.7M
Q2 25
$12.0M
$-157.9M
Q1 25
$2.4M
$-44.9M
Q4 24
$12.5M
$-108.2M
Q3 24
$9.3M
$-93.0M
Q2 24
$19.6M
$-143.8M
Gross Margin
COLL
COLL
HR
HR
Q1 26
Q4 25
62.5%
Q3 25
61.7%
Q2 25
57.7%
Q1 25
54.8%
Q4 24
54.0%
Q3 24
60.8%
Q2 24
62.5%
Operating Margin
COLL
COLL
HR
HR
Q1 26
Q4 25
29.6%
Q3 25
29.7%
Q2 25
18.7%
Q1 25
12.2%
Q4 24
20.9%
Q3 24
21.9%
Q2 24
32.7%
Net Margin
COLL
COLL
HR
HR
Q1 26
-0.0%
Q4 25
8.3%
183.4%
Q3 25
15.0%
-19.4%
Q2 25
6.4%
-53.1%
Q1 25
1.4%
-15.0%
Q4 24
6.9%
-1924.1%
Q3 24
5.9%
-29.5%
Q2 24
13.5%
-45.5%
EPS (diluted)
COLL
COLL
HR
HR
Q1 26
$0.00
Q4 25
$0.48
$0.04
Q3 25
$0.84
$-0.17
Q2 25
$0.34
$-0.45
Q1 25
$0.07
$-0.13
Q4 24
$0.36
$-0.34
Q3 24
$0.27
$-0.26
Q2 24
$0.52
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COLL
COLL
HR
HR
Cash + ST InvestmentsLiquidity on hand
$386.7M
$26.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$301.7M
$4.4B
Total Assets
$1.7B
$9.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COLL
COLL
HR
HR
Q1 26
$26.2M
Q4 25
$386.7M
$26.2M
Q3 25
$285.9M
$43.3M
Q2 25
$222.2M
$25.5M
Q1 25
$197.8M
$25.7M
Q4 24
$162.8M
$68.9M
Q3 24
$120.0M
$22.8M
Q2 24
$271.6M
$41.8M
Total Debt
COLL
COLL
HR
HR
Q1 26
Q4 25
$3.9B
Q3 25
$4.5B
Q2 25
$4.7B
Q1 25
$4.7B
Q4 24
$4.7B
Q3 24
$5.0B
Q2 24
$5.1B
Stockholders' Equity
COLL
COLL
HR
HR
Q1 26
$4.4B
Q4 25
$301.7M
$4.6B
Q3 25
$274.8M
$4.7B
Q2 25
$232.2M
$4.8B
Q1 25
$234.4M
$5.1B
Q4 24
$228.8M
$5.2B
Q3 24
$234.3M
$5.5B
Q2 24
$216.6M
$5.9B
Total Assets
COLL
COLL
HR
HR
Q1 26
$9.1B
Q4 25
$1.7B
$9.2B
Q3 25
$1.6B
$9.9B
Q2 25
$1.6B
$10.2B
Q1 25
$1.6B
$10.5B
Q4 24
$1.7B
$10.7B
Q3 24
$1.6B
$11.2B
Q2 24
$1.1B
$11.8B
Debt / Equity
COLL
COLL
HR
HR
Q1 26
Q4 25
0.85×
Q3 25
0.96×
Q2 25
0.97×
Q1 25
0.93×
Q4 24
0.89×
Q3 24
0.90×
Q2 24
0.87×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COLL
COLL
HR
HR
Operating Cash FlowLast quarter
$123.0M
Free Cash FlowOCF − Capex
$122.4M
FCF MarginFCF / Revenue
59.6%
Capex IntensityCapex / Revenue
0.3%
9.7%
Cash ConversionOCF / Net Profit
7.25×
TTM Free Cash FlowTrailing 4 quarters
$327.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COLL
COLL
HR
HR
Q1 26
Q4 25
$123.0M
$457.1M
Q3 25
$78.4M
$113.8M
Q2 25
$72.4M
$163.2M
Q1 25
$55.4M
$47.8M
Q4 24
$84.6M
$501.6M
Q3 24
$-9.0M
$119.3M
Q2 24
$67.4M
$168.2M
Free Cash Flow
COLL
COLL
HR
HR
Q1 26
Q4 25
$122.4M
Q3 25
$78.3M
Q2 25
$72.4M
Q1 25
$54.6M
Q4 24
$84.1M
Q3 24
$-9.2M
Q2 24
$67.1M
FCF Margin
COLL
COLL
HR
HR
Q1 26
Q4 25
59.6%
Q3 25
37.4%
Q2 25
38.5%
Q1 25
30.7%
Q4 24
46.2%
Q3 24
-5.8%
Q2 24
46.2%
Capex Intensity
COLL
COLL
HR
HR
Q1 26
9.7%
Q4 25
0.3%
Q3 25
0.1%
Q2 25
0.0%
Q1 25
0.4%
Q4 24
0.3%
Q3 24
0.2%
Q2 24
0.2%
Cash Conversion
COLL
COLL
HR
HR
Q1 26
Q4 25
7.25×
31.33×
Q3 25
2.49×
Q2 25
6.05×
Q1 25
22.92×
Q4 24
6.75×
Q3 24
-0.96×
Q2 24
3.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COLL
COLL

Segment breakdown not available.

HR
HR

Rental income$267.6M96%
Other$11.4M4%

Related Comparisons